I thought this was good news. AstraZeneca's vaccine was getting bad press before it was even released as an "experimental" vaccine. Glad Canada's finally followed the example of around 20 countries on this...
**
After previously defending AstraZeneca’s COVID vaccine, Canadian health officials on Monday suspended its use in people 55 and under, pending outcome of a detailed risk-benefit analysis.
Canadian health officials on Monday suspended use of the Oxford-AstraZeneca COVID vaccine for people under age 55 following concerns the vaccine might be linked to rare blood clots, according to U.S. News & World Report.
“There is substantial uncertainty about the benefit of providing AstraZeneca COVID-19 vaccines to adults under 55 given the potential risks,” said Dr. Shelley Deeks, vice chair of the National Advisory Committee on Immunization.
According to ABC News, Deeks said the committee updated its recommendations amid new data from Europe suggesting the risk of blood clots is now potentially one in 100,000 — much higher than the one-in-1-million risk stated before.
Most of the patients in Europe who developed a rare blood clot after vaccination with AstraZeneca were women under age 55, and the fatality rate among those who developed clots is as high as 40%.
**
Full article here:
**
After previously defending AstraZeneca’s COVID vaccine, Canadian health officials on Monday suspended its use in people 55 and under, pending outcome of a detailed risk-benefit analysis.
Canadian health officials on Monday suspended use of the Oxford-AstraZeneca COVID vaccine for people under age 55 following concerns the vaccine might be linked to rare blood clots, according to U.S. News & World Report.
“There is substantial uncertainty about the benefit of providing AstraZeneca COVID-19 vaccines to adults under 55 given the potential risks,” said Dr. Shelley Deeks, vice chair of the National Advisory Committee on Immunization.
According to ABC News, Deeks said the committee updated its recommendations amid new data from Europe suggesting the risk of blood clots is now potentially one in 100,000 — much higher than the one-in-1-million risk stated before.
Most of the patients in Europe who developed a rare blood clot after vaccination with AstraZeneca were women under age 55, and the fatality rate among those who developed clots is as high as 40%.
**
Full article here:
Canada Does About Face on AstraZeneca Vaccine, Citing Blood Clot Concerns
After previously defending AstraZeneca’s COVID vaccine, Canadian health officials on Monday suspended its use in people 55 and under, pending outcome of a detailed risk-benefit analysis.
childrenshealthdefense.org